» Articles » PMID: 29482336

Advanced Oxidation Protein Products Aggravate Tubulointerstitial Fibrosis Through Protein Kinase C-Dependent Mitochondrial Injury in Early Diabetic Nephropathy

Overview
Specialty Endocrinology
Date 2018 Feb 28
PMID 29482336
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Diabetic nephropathy (DN) is the most common microvascular complications and the principal cause of mortality and morbidity rates in patients with diabetes. The expression of advanced oxidation protein products (AOPPs) has been found in vacuolated renal tubules in DN and correlated with patients' decreased renal function. The accumulation of AOPPs is regarded as an initiating factor in podocyte injuries via the protein kinase C (PKC) signaling, which plays a critical role in triggering oxidative stress and mitochondrial injuries in diseases including DN. Whether AOPPs could induce mitochondrial injuries and fibrosis in renal tubules remains largely unknown. Herein, we tested the hypothesis that the accumulation of AOPPs in diabetes incurs mitochondrial dysfunction and oxidative stress, causing renal tubulointerstitial fibrosis (TIF) via PKC signaling pathway.

Results: In vivo, intrarenal AOPPs accumulation correlated with oxidative stress, renal fibrosis, proteinuria, and declined renal function in DN patients and diabetic rats. AOPPs-induced mitochondrial injuries, apoptosis, and TIF were significantly mitigated by PKCη inhibition in diabetic rats. In vitro, high glucose (HG) stimulated AOPP expression and augmented PKC-mediated oxidative stress and fibrosis in HK-2 cells. Furthermore, we provide mechanistic evidence that inhibition of PKCη isoform alleviated mitochondrial injuries and function, attenuated apoptosis, and renal fibrosis in HG-cultured AOPPs-induced HK-2 cells. Innovation and Conclusion: We propose a novel mechanism that AOPPs-induced mitochondrial dysfunction and oxidative stress cause TIF in DN via activation of the PKCη isoform.

Citing Articles

Cellular cross-talk drives mesenchymal transdifferentiation in diabetic kidney disease.

Chatterjee A, Tumarin J, Prabhakar S Front Med (Lausanne). 2025; 11():1499473.

PMID: 39839616 PMC: 11747801. DOI: 10.3389/fmed.2024.1499473.


A previously unidentified circRNA inhibits virus replication by regulating the miR-24-3p/KEAP1 axis.

Li H, Du L, Li J, Huang Y, Lu C, Deng T PLoS Pathog. 2024; 20(12):e1012712.

PMID: 39689152 PMC: 11651552. DOI: 10.1371/journal.ppat.1012712.


Unveiling the Predictive Model for Macrovascular Complications in Type 2 Diabetes Mellitus: microRNAs Expression, Lipid Profile, and Oxidative Stress Markers.

Duisenbek A, Aviles Perez M, Perez M, Aguilar Benitez J, Pereira Perez V, Gorts Ortega J Int J Mol Sci. 2024; 25(21).

PMID: 39519313 PMC: 11546857. DOI: 10.3390/ijms252111763.


Microarray Expression Profile of Exosomal circRNAs from High Glucose Stimulated Human Renal Tubular Epithelial Cells.

Sha Y, Cao S, Zhang L, Lai L, Ke P, Yu K Diabetes Metab Syndr Obes. 2023; 16:3937-3951.

PMID: 38077483 PMC: 10710189. DOI: 10.2147/DMSO.S430131.


Tanshinone IIA is superior to paricalcitol in ameliorating tubulointerstitial fibrosis through regulation of VDR/Wnt/β-catenin pathway in rats with diabetic nephropathy.

Zeng J, Wang Y, Hong F, Miao M, Jiang Y, Qiao Z Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(6):3959-3977.

PMID: 37991543 PMC: 11111530. DOI: 10.1007/s00210-023-02853-3.